Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Thiourea
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Thiourea

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

A photographic fixative used also in the manufacture of resins.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (655 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are antithyroid agents and/or free radical scavengers.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Where it fits in the MeSH classification

Broader topics
Urea; Sulfur Compounds
Narrower topics
beta-Aminoethyl Isothiourea; Burimamide; Dimaprit; Ethylenethiourea; Guanylthiourea; Isothiuronium; Methallibure; Metiamide; Noxythiolin; Phenylthiourea

Related concepts

  • Antithyroid Agents
  • Free Radical Scavengers

Research landscape

PubMed indexes 10,528 records tagged with the MeSH heading “Thiourea” (counts retrieved 2026-10-31). 909 of them (8.6%) were published from 2020 onward, and the busiest period so far is through 1999 with 6,001 records.

Reviews account for 266 records (2.5%) and meta-analyses for 4. Randomized controlled trials number 26 (0.2%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 6,001 records; 2000-2009: 1,679 records; 2010-2019: 1,939 records; 2020 onward: 909 records6,001through 19991,6792000-20091,9392010-20199092020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19996,001
2000-20091,679
2010-20191,939
2020 onward909
Share of records by publication typeReviews: 2.5 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.2 percentReviews2.5% (266)Meta-analyses0.0% (4)Randomized controlled trials0.2% (26)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 10,528 PubMed records
TypeRecordsShare
Reviews2662.5%
Meta-analyses40.0%
Randomized controlled trials260.2%

Method: PubMed query "Thiourea"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Experimental Evidence Shows Salubrinal, an eIF2α Dephosphorylation Inhibitor, Reduces Xenotoxicant-Induced Cellular Damage
Matsuoka M, Komoike Y
2015Review article
Design not recorded in structured metadata
66cc by
PMID 26193263 · DOI · PMC4519949
Aerial application of mancozeb and urinary ethylene thiourea (ETU) concentrations among pregnant women in Costa Rica: the Infants' Environmental Health Study (ISA)
van Wendel de Joode B, Mora AM, Córdoba L, Cano JC, Quesada R, Faniband M, et al.
2014Research article
Design not recorded in structured metadata
53cc0
PMID 25198283 · DOI · PMC4256696
Antiviral activity and mechanism of action of novel thiourea containing chiral phosphonate on tobacco mosaic virus
Fan H, Song B, Bhadury PS, Jin L, Hu D, Yang S
2011Research article
Design not recorded in structured metadata
45cc by
PMID 21845094 · DOI · PMC3155367
Discovery of bis-thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study
Sabuakham S, Nasoontorn S, Nuramrum N, Silsirivanit A, Rungrotmongkol T, Pingaew R, et al.
2025Research article
Design not recorded in structured metadata
5cc by
PMID 40556424 · DOI · PMC12897533

Experimental Evidence Shows Salubrinal, an eIF2α Dephosphorylation Inhibitor, Reduces Xenotoxicant-Induced Cellular Damage [1]

Review article Matsuoka M, Komoike Y · · 2015 · cited 66 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Accumulating evidence indicates that endoplasmic reticulum (ER) stress and the subsequent unfolded protein response (UPR) are involved in the pathogenesis of not only the protein misfolding disorders such as certain neurodegenerative and metabolic diseases, but also in the cytotoxicity of environmental pollutants, industrial chemicals, and drugs.
Closing excerpt
The canonical and other possible mechanisms of cytoprotection by salubrinal from xenotoxicant-induced ER stress are also discussed.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (174 words)

Accumulating evidence indicates that endoplasmic reticulum (ER) stress and the subsequent unfolded protein response (UPR) are involved in the pathogenesis of not only the protein misfolding disorders such as certain neurodegenerative and metabolic diseases, but also in the cytotoxicity of environmental pollutants, industrial chemicals, and drugs. Thus, the modulation of ER stress signaling pathways is an important issue for protection against cellular damage induced by xenotoxicants. The substance salubrinal has been shown to prevent dephosphorylation of the eukaryotic translation initiation factor 2 alpha (eIF2α). The phosphorylation of eIF2α appears to be cytoprotective during ER stress, because inhibition of the translation initiation activity of eIF2α reduces global protein synthesis. In addition, the expression of activating transcription factor 4 (ATF4), a transcription factor that induces the expression of UPR target genes, is up-regulated through alternative translation. This review shows that salubrinal can protect cells from the damage induced by a wide range of xenotoxicants, including environmental pollutants and drugs. The canonical and other possible mechanisms of cytoprotection by salubrinal from xenotoxicant-induced ER stress are also discussed.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26193263 · DOI · PMC4519949

Aerial application of mancozeb and urinary ethylene thiourea (ETU) concentrations among pregnant women in Costa Rica: the Infants' Environmental Health Study (ISA) [2]

Research article van Wendel de Joode B, Mora AM, Córdoba L, Cano JC, Quesada R, Faniband M, et al. · · 2014 · cited 53 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
BackgroundMancozeb and its main metabolite ethylene thiourea (ETU) may alter thyroid function; thyroid hormones are essential for fetal brain development.
Closing excerpt
The factors predicting ETU provide insight into possibilities for exposure reduction.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (187 words)

BackgroundMancozeb and its main metabolite ethylene thiourea (ETU) may alter thyroid function; thyroid hormones are essential for fetal brain development. In Costa Rica, mancozeb is aerially sprayed at large-scale banana plantations on a weekly basis.ObjectivesOur goals were to evaluate urinary ETU concentrations in pregnant women living near large-scale banana plantations, compare their estimated daily intake (EDI) with established reference doses (RfDs), and identify factors that predict their urinary ETU concentrations.MethodsWe enrolled 451 pregnant women from Matina County, Costa Rica, which has large-scale banana production. We visited 445 women up to three times during pregnancy to obtain urine samples (n = 872) and information on factors that possibly influence exposure. We determined urinary ETU concentrations using liquid chromatography mass spectrometry.ResultsPregnant women's median urinary ETU concentrations were more than five times higher than those reported for other general populations. Seventy-two percent of the women had EDIs above the RfD. Women who lived closest (1st quartile, ConclusionsThe pregnant women's urinary ETU concentrations are of concern, and the principal source of exposure is likely to be aerial spraying of mancozeb. The factors predicting ETU provide insight into possibilities for exposure reduction.

Abstract reproduced from the open-access article under the recorded cc0 licence; © the authors. PMID 25198283 · DOI · PMC4256696

Antiviral activity and mechanism of action of novel thiourea containing chiral phosphonate on tobacco mosaic virus [3]

Research article Fan H, Song B, Bhadury PS, Jin L, Hu D, Yang S · · 2011 · cited 45 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Using half-leaf method O,O'-diisopropyl (3-(L-1-(benzylamino)-1-oxo-3- phenylpropan-2-yl)thioureido)(phenyl)methyl phosphonate (2009104) was studied for its activity on tobacco mosaic virus (TMV).
Closing excerpt
The study of the effect of compound 2009104 on TMV capsid protein (CP) showed that it inhibited the polymerization process of TMV-CP in vitro.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (143 words)

Using half-leaf method O,O'-diisopropyl (3-(L-1-(benzylamino)-1-oxo-3- phenylpropan-2-yl)thioureido)(phenyl)methyl phosphonate (2009104) was studied for its activity on tobacco mosaic virus (TMV). It showed good curative activity in vivo and the curative activity at 500 μg/mL was found to be 53.3%. In vivo treatment with the control agent Ningnanmycin at 500 μg/mL resulted in 51.2% inhibition and curative inhibition rates respectively. Dot-ELISA test was employed to verify the efficacy of activity of compound 200910 for anti-TMV activity. The mechanism of action of compound 2009104 to resist TMV was also studied. The results showed that the resistance enzymes PAL, POD, SOD activity and chlorophyll content after TMV inoculation K(326) (Nicotiana tabacum K(326)) of tobacco plants followed by treatment with compound 2009104 were significantly enhanced. The study of the effect of compound 2009104 on TMV capsid protein (CP) showed that it inhibited the polymerization process of TMV-CP in vitro.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 21845094 · DOI · PMC3155367

Discovery of bis-thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study [4]

Research article Sabuakham S, Nasoontorn S, Nuramrum N, Silsirivanit A, Rungrotmongkol T, Pingaew R, et al. · · 2025 · cited 5 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Tyrosinase, a key enzyme in melanin synthesis, serves as a primary target for developing depigmenting agents.
Closing excerpt
Drug-likeness predictions confirmed its compliance with Lipinski's rule of five, supporting bis-thiourea derivatives as promising tyrosinase inhibitors.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (151 words)

Tyrosinase, a key enzyme in melanin synthesis, serves as a primary target for developing depigmenting agents. The search for novel tyrosinase inhibitors is needed due to the adverse effects of current inhibitors. This study evaluated 16 bis-thiourea derivatives using in vitro and in silico methods, identifying compound 4, with chlorine substituents, as the most potent inhibitor. Compound 4 outperformed kojic acid in inhibiting mushroom tyrosinase activity and interacted with catalytic copper ions and active site residues, as revealed by molecular docking and copper-chelating assay. Molecular dynamics simulation and MM/PBSA-based free energy calculations confirmed the greater stability and binding affinity of the compound 4-tyrosinase complex in an aqueous environment compared to kojic acid-tyrosinase complex. Melanin assay revealed that compound 4 significantly suppressed melanin production in B16F10 melanoma cells, showing stronger anti-melanogenic activity than kojic acid. Drug-likeness predictions confirmed its compliance with Lipinski's rule of five, supporting bis-thiourea derivatives as promising tyrosinase inhibitors.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40556424 · DOI · PMC12897533

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article (Thio)urea organocatalysis--what can be learnt from anion recognition? [5]
    Zhang Z, Schreiner PR · Chem Soc Rev · 2009 · cited 571 times (Europe PMC)
  • Research article PTC/PROP tasting: anatomy, psychophysics, and sex effects [6]
    Bartoshuk LM, Duffy VB, Miller IJ · Physiol Behav · 1994 · cited 468 times (Europe PMC)
  • Research article Anion complexation and sensing using modified urea and thiourea-based receptors [7]
    Li AF, Wang JH, Wang F, Jiang YB · Chem Soc Rev · 2010 · cited 248 times (Europe PMC)
  • Research article Organocatalytic asymmetric epoxidation and aziridination of olefins and their synthetic applications [8]
    Zhu Y, Wang Q, Cornwall RG, Shi Y · Chem Rev · 2014 · cited 223 times (Europe PMC)
  • Research article Amidines, isothioureas, and guanidines as nucleophilic catalysts [9]
    Taylor JE, Bull SD, Williams JM · Chem Soc Rev · 2012 · cited 218 times (Europe PMC)
  • Research article Development of chiral thiourea catalysts and its application to asymmetric catalytic reactions [10]
    Takemoto Y · Chem Pharm Bull (Tokyo) · 2010 · cited 181 times (Europe PMC)

References

  1. Matsuoka M, Komoike Y. Experimental Evidence Shows Salubrinal, an eIF2α Dephosphorylation Inhibitor, Reduces Xenotoxicant-Induced Cellular Damage. . 2015. PMID 26193263 · DOI · PMC4519949
  2. van Wendel de Joode B, Mora AM, Córdoba L, Cano JC, Quesada R, Faniband M, et al.. Aerial application of mancozeb and urinary ethylene thiourea (ETU) concentrations among pregnant women in Costa Rica: the Infants' Environmental Health Study (ISA). . 2014. PMID 25198283 · DOI · PMC4256696
  3. Fan H, Song B, Bhadury PS, Jin L, Hu D, Yang S. Antiviral activity and mechanism of action of novel thiourea containing chiral phosphonate on tobacco mosaic virus. . 2011. PMID 21845094 · DOI · PMC3155367
  4. Sabuakham S, Nasoontorn S, Nuramrum N, Silsirivanit A, Rungrotmongkol T, Pingaew R, et al.. Discovery of bis-thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study. . 2025. PMID 40556424 · DOI · PMC12897533
  5. Zhang Z, Schreiner PR. (Thio)urea organocatalysis--what can be learnt from anion recognition?. Chem Soc Rev. 2009. PMID 19421588 · DOI
  6. Bartoshuk LM, Duffy VB, Miller IJ. PTC/PROP tasting: anatomy, psychophysics, and sex effects. Physiol Behav. 1994. PMID 7878086 · DOI
  7. Li AF, Wang JH, Wang F, Jiang YB. Anion complexation and sensing using modified urea and thiourea-based receptors. Chem Soc Rev. 2010. PMID 20737072 · DOI
  8. Zhu Y, Wang Q, Cornwall RG, Shi Y. Organocatalytic asymmetric epoxidation and aziridination of olefins and their synthetic applications. Chem Rev. 2014. PMID 24785198 · DOI
  9. Taylor JE, Bull SD, Williams JM. Amidines, isothioureas, and guanidines as nucleophilic catalysts. Chem Soc Rev. 2012. PMID 22234578 · DOI
  10. Takemoto Y. Development of chiral thiourea catalysts and its application to asymmetric catalytic reactions. Chem Pharm Bull (Tokyo). 2010. PMID 20460782 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • SorafenibDrugs and Chemicals
  • StreptozocinDrugs and Chemicals
  • TolbutamideDrugs and Chemicals
  • UreaDrugs and Chemicals
  • Free Radical ScavengersPharmacology
  • ExcipientsDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

10,528
PubMed records on this heading
9%
published since 2020
266
review articles
26
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • SorafenibDrugs and Chemicals
  • StreptozocinDrugs and Chemicals
  • TolbutamideDrugs and Chemicals
  • UreaDrugs and Chemicals
  • Free Radical ScavengersPharmacology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support